PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES

1. A process for preparing a pseudotetrapeptide compound of formula or a salt or prodrug thereof wherein is optionally amino protected 4-8 membered azaheterocyclyl; is a single or double bond; q is 1-5; B is C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkylC1-C20alkyl, C1-C20alkylC3-C10cycloalkyl, C1-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MENCEL, JAMES, J, LAVIGNE, MICHEL, DAUBIE, CHRISTOPHE, LEON, PATRICK, VANASSE, BENOIT, J, LIU, ROBERT, C, STAMMLER, ROBERT, D'NETTO, GEOFFREY, A
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1. A process for preparing a pseudotetrapeptide compound of formula or a salt or prodrug thereof wherein is optionally amino protected 4-8 membered azaheterocyclyl; is a single or double bond; q is 1-5; B is C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkylC1-C20alkyl, C1-C20alkylC3-C10cycloalkyl, C1-C20alkylC3-C10cycloalkylC1-C20alkyl, C6-C10aryl, C6-C10arC1-C20alkyl, C1-C20alkylC6-C10aryl or C1-C20alkylC6-C10arC1-C20alkyl; Q2 is H or a carboxy protecting group; J is -H, C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkylC1-C20alkyl, C1-C20alkylC3-C10cycloalkyl, C1-C20alkylC3-C10cycloalkylC1-C20alkyl, C6-C10aryl, substituted C6-C10aryl, C6-C10arC1-C20alkyl or substituted C6-C10arC1-C20alkyl; L is OR , or NR R , where R and R are independently -H, C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkyl C1-C20alkyl,C1-C20alkyl C3-C10cycloalkyl, C1-C20alkyl C3-C10cycloalkyl C1-C20alkyl, C6-C10aryl, C6-C10ar C1-C20alkyl,C1-C20alkyl C6-C10aryl, or C1-C20alkyl C6-C10ar C1-C20alkyl, and p is 1 or 2, comprising (a) coupling an azaheterocyclyl pseudodipeptide of formula or a salt thereof wherein K is OH or an acyl activating group, with a carboxylic acid substituted dipeptide of formula or a salt thereof; (b) optionally removing the amino protecting group or carboxylic acid protecting group and (c) optionally converting the pseudotetrapeptide to the salt or prodrug. 2. The process of Claim 1 wherein is a group of formula wherein m is 1 to 5, preferably 3; n is 2-6, preferably 3 or 4; and P1 is an amino protecting group, wherein Q2 is a carboxy protecting group; wherein B is C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkylC1-C20alkyl, C1-C20alkyl C3-C10cycloalkyl, or C1-C20alkyl C3-C10cycloalkyl C1-C20alkyl, J is -H, C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkyl C1-C20alkyl,C1-C20alkyl C3-C10cycloalkyl, or C1-C20alkyl C3-C10cycloalkyl C1-C20alkyl. 3. The process of Claim 2 wherein B is C1-C20alkyl, J is C1-C20alkyl, C3-C10cycloalkyl, or C3-C10cycloalkyl C1-C20alkyl, R and R are independently -H, C1-C20alkyl, C3-C10cycloalkyl, C3-C10cycloalkyl C1-C20alkyl, C1-C20alkyl C3-C10cycloalkyl, C1-C20alkyl C3-C10cycloalkyl C1-C20alkyl or C6-C10ar C1-C20alkyl, m is 3, n is 3 or 4, and p is 1. P1 is benzyloxycarbonyl and Q2 is H or benzyl, L is -NR R . 4. The process of Claim 1 wherein the salt of the azaheterocyclyl pseudodipeptide is coupled with the salt of the carboxylic acid substituted dipeptide or wherein a base addition salt of the azaheterocyclyl pseudodipeptide is coupled with an